本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

10.91
+0.48004.60%
盤後10.910.00000.00%19:30 EDT
成交量:79.99萬
成交額:872.84萬
市值:9.51億
市盈率:-5.12
高:11.02
開:10.60
低:10.60
收:10.43
52周最高:36.26
52周最低:5.36
股本:8,715.70萬
流通股本:7,188.81萬
量比:0.76
換手率:1.11%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
淨資產收益率:-52.74%
總資產收益率:-31.82%
市淨率:2.21
市盈率(LYR):-5.83

資料載入中...

2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]